Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares conducted on December 5, 2025, and filed on December 8, 2025. The Company, a foreign private issuer, executed a share repurchase through BNP Paribas SA as part of an existing buyback programme established under a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing details a specific block of share purchases rather than full-period financial results. Key metrics for the transaction on December 5, 2025, include:
- Shares Purchased: 248,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,798.00 GBp; highest price paid was 1,833.00 GBp.
- Average Price: Volume-weighted average price paid was 1,818.74 GBp.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON.
Since the commencement of the programme on September 30, 2025, the Company has purchased a total of 12,245,733 ordinary shares. Following this transaction, the Company holds 237,710,577 ordinary shares in treasury. The total number of ordinary shares in issue (excluding treasury shares) is 4,077,728,560, which corresponds to the total voting rights.
Material Changes and Capital Structure
The primary material change reported is the reduction of shares in issue and the increase in treasury holdings. The percentage of voting rights attributable to ordinary shares held in treasury is now 5.83%. The filing does not provide comparative financial data (revenue, profit, or cash flow) for the period, as it is a transaction-specific report.
Guidance, Outlook, and Risks
The filing contains no new financial guidance or management commentary regarding operational outlook. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the Company's 2024 Annual Report on Form 20-F and Q3 2025 Results. The purchase was effected pursuant to a non-discretionary agreement, indicating a structured approach to capital return.
Investor Verification Checklist
- Verify the total number of shares in issue (4,077,728,560) for accurate calculation of ownership percentages under Disclosure Guidance and Transparency Rules.
- Confirm the current treasury share percentage (5.83%) against regulatory thresholds for voting rights.
- Review the non-discretionary agreement terms announced on September 30, 2025, to understand the remaining scope of the buyback programme.
- Check the 2024 Form 20-F and Q3 2025 Results for the risk factors referenced in the cautionary statement.